The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study
Open accessAbstract
Proton pump inhibitors (PPIs) are widely used to treat gastro-esophageal reflux and prevent gastric ulcers, and have been considered as low risk. However, recent studies have identified possible associations between PPI use and gut microbiota, suggesting that PPIs use increases the risk of enteric infections, including Clostridium difficile infection. To investigate gut microbiota in Japanese PPIs users, we conducted 16S metagenomics analysis of fecal samples collected from PPI users and healthy adults. In total, 36 PPI users and 36 PPI non-users (as control subjects) matched by age and sex were recruited and fecal samples were obtained to analyze the gut microbiome using 16S rRNA gene sequencing. There were significant differences in the microbial structure between PPI non-users and PPI users. In contrast, the analysis of α-diversity revealed no significant differences between PPI non-users and PPI users. When comparing in genus level between these two groups, the genera Streptococcus was significantly abundant and the genera Faecalibacterium was significantly decreased in PPI users. Our findings indicate a probable association between PPI use and the alternation of microbiota. These alterations might provide a mechanism by which PPIs predispose enteric infection such as Clostridium difficile infection.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PPI-driven gastric hypochlorhydria can cause significant changes in gut microbiota composition.
“likely due to PPI-driven gastric hypo-chlorhydria, which can cause also significant changes in gut microbiota composition[9-11]”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · see citing works
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,617 · see citing works
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114 · see citing works
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116 · see citing works
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548 · see citing works
STAMP: statistical analysis of taxonomic and functional profiles
Parks, D. H., Tyson, G. W., Hugenholtz, P., & Beiko, R. G. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu494 · Cited by 4,200 · see citing works
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637 · see citing works
Data, information, knowledge and principle: back to metabolism in KEGG
Kanehisa, M. I., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1076 · Cited by 3,103 · see citing works
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · see citing works
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371 · cited 2× · see citing works
“(4,17) In our results, as shown in Fig.”
Freedberg, D. E., Kim, L. S., & Yang, Y. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 896 · see citing works
Proton pump inhibitors alter the composition of the gut microbiota
Jackson, M. A., Goodrich, J. K., Maxan, M.-E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310861 · Cited by 895 · see citing works
Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis
Kwok, C. S., Arthur, A. K., Anibueze, C. I., Singh, S., Cavallazzi, R., & Loke, Y. K. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.108 · Cited by 579 · see citing works
Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis
Janarthanan, S., Ditah, I., Adler, D. G., & Ehrinpreis, M. N. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.179 · Cited by 538 · see citing works
Complications of Proton Pump Inhibitor Therapy
Vaezi, M. F., Yang, Y., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.047 · Cited by 484 · see citing works
Freedberg, D. E., Toussaint, N. C., Chen, S. P., Ratner, A. J., Whittier, S., Wang, T. C., Wang, H. H., & Abrams, J. A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.043 · Cited by 322 · see citing works
Packey, C. D., & Sartor, R. B. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832a8a5d · Cited by 319 · see citing works
A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors
Clooney, A. G., Bernstein, C. N., Leslie, W. D., Vagianos, K., Sargent, M., Laserna‐Mendieta, E. J., Claesson, M. J., & Targownik, L. E. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13568 · Cited by 166 · see citing works
Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
Tsuda, A., Suda, W., Morita, H., Takanashi, K., Takagi, A., Koga, Y., & Hattori, M. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.20 · Cited by 164 · see citing works
García-Mazcorro, J. F., Suchodolski, J. S., Jones, K. R., Clark‐Price, S. C., Dowd, S. E., Minamoto, Y., Markel, M. E., Steiner, J. M., & Dossin, O. (2012) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2012.01331.x · Cited by 150 · see citing works
Inoüe, R., Ohue‐Kitano, R., Tsukahara, T., Tanaka, M., Masuda, S., Inoue, T., Yamakage, H., Kusakabe, T., Hasegawa, K., Shimatsu, A., et al. (2017) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-44 · Cited by 117 · see citing works
Otsuka, T., Sugimoto, M., Inoüe, R., Ohno, M., Ban, H., Nishida, A., Inatomi, O., Takahashi, S., Naito, Y., & Andoh, A. (2016) · Gut · doi:10.1136/gutjnl-2016-313312 · Cited by 78 · see citing works
Self-citationDörffel, Y., Swidsinski, A. V., Loening-Baucke, V. A., Wiedenmann, B. J., & Pavel, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21923 · Cited by 45 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Impact of commonly used drugs on the composition and metabolic function of the gut microbiota
Vich Vila, A., Collij, V., Sanna, S., Sinha, T., Imhann, F., Bourgonje, A. R., Mujagic, Z., Jonkers, D. M. A. E., Masclee, A. A. M., Fu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14177-z · Cited by 791 · see citing works
Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566 · see citing works
Microbiota-Gut-Brain Axis: New Therapeutic Opportunities
Long-Smith, C., O'Riordan, K. J., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023628 · Cited by 419 · see citing works
Dysbiosis of the gut and lung microbiome has a role in asthma
Hufnagl, K., Pali‐Schöll, I., Roth‐Walter, F., & Jensen‐Jarolim, E. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-019-00775-y · Cited by 370 · see citing works
Takagi, T., Naito, Y., Inoüe, R., Kashiwagi, S., Uchiyama, K., Mizushima, K., Tsuchiya, S., Dohi, O., Yoshida, N., Kamada, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1488-5 · Cited by 310 · see citing works
Self-citationProton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258 · see citing works
Aging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease
Haran, J. P., & McCormick, B. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.09.060 · Cited by 220 · see citing works
Mechanisms of proton pump inhibitor‐induced hypomagnesemia
Gommers, L. M. M., Hoenderop, J. G. J., & de Baaij, J. H. F. (2022) · Acta Physiologica · doi:10.1111/apha.13846 · Cited by 130 · see citing works
Macke, L., Schulz, C., Koletzko, L., & Malfertheiner, P. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15604 · Cited by 118 · see citing works
Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors
Hojo, M., Asahara, T., Nagahara, A., Takeda, T., Matsumoto, K., Ueyama, H., Matsumoto, K., Asaoka, D., Takahashi, T., Nomoto, K., et al. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5122-4 · Cited by 114 · see citing works
Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use
Naito, Y., Kashiwagi, K., Takagi, T., Andoh, A., & Inoüe, R. (2018) · Digestion · doi:10.1159/000481813 · Cited by 109 · see citing works
Self-citationBaxter, N. T., Lesniak, N. A., Sinani, H., Schloss, P. D., & Koropatkin, N. M. (2019) · mSphere · doi:10.1128/msphere.00528-18 · Cited by 96 · see citing works
Takagi, T., Naito, Y., Kashiwagi, S., Uchiyama, K., Mizushima, K., Kamada, K., Ishikawa, T., Inoüe, R., Okuda, K., Tsujimoto, Y., et al. (2020) · Nutrients · doi:10.3390/nu12102996 · Cited by 89 · see citing works
Self-citationXia, B., Yang, M. G., Nguyen, L. H., He, Q., Zhen, J., Yu, Y., Di, M., Qin, X. S., Lu, K., Kuo, Z. C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.005 · Cited by 86 · see citing works
Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
Bodai, B. I., & Nakata, T. E. (2020) · The Permanente Journal · doi:10.7812/tpp/19.129 · Cited by 72 · see citing works
Xiao, X., Zhang, X., Wang, J., Liu, Y., Yan, H., Xing, X., & Yang, J. (2024) · Gut · doi:10.1136/gutjnl-2023-330883 · Cited by 69 · see citing works
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation
Uchiyama, K., Naito, Y., & Takagi, T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.006 · Cited by 64 · see citing works
Self-citationGut microbiota in dementia with Lewy bodies
Nishiwaki, H., Ueyama, J., Kashihara, K., Ito, M., Hamaguchi, T., Maeda, T., Tsuboi, Y., Katsuno, M., Hirayama, M., & Ohno, K. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00428-2 · Cited by 58 · see citing works
Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota
Zhang, J., Zhang, C., Zhang, Q., Yu, L., Chen, W., Xue, Y., & Zhai, Q. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02895-w · Cited by 65 · see citing works
Role of the duodenal microbiota in functional dyspepsia
Brown, G., Hoedt, E. C., Keely, S., Shah, A., Walker, M. M., Holtmann, G., & Talley, N. J. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14372 · Cited by 56 · see citing works
Nadatani, Y., Watanabe, T., Suda, W., Nakata, A., Matsumoto, Y., Kosaka, S., Higashimori, A., Otani, K., Hosomi, S., Tanaka, F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53559-7 · Cited by 55 · see citing works
Intake of sucrose affects gut dysbiosis in patients with type 2 diabetes
Hashimoto, Y., Hamaguchi, M., Kaji, A., Sakai, R., Osaka, T., Inoüe, R., Kashiwagi, S., Mizushima, K., Uchiyama, K., Takagi, T., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13293 · Cited by 52 · see citing works
Self-citationHelicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle
Liatsos, C. N., Papaefthymiou, A., Kyriakos, N., Galanopoulos, M., Doulberis, M., Giakoumis, M., Petridou, E., Mavrogiannis, C. C., Rokkas, T., & Kountouras, J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i5.959 · Cited by 52 · see citing works
Country-wide medical records infer increased allergy risk of gastric acid inhibition
Jordakieva, G., Kundi, M., Untersmayr, E., Pali‐Schöll, I., Reichardt, B., & Jensen‐Jarolim, E. (2019) · Nature Communications · doi:10.1038/s41467-019-10914-6 · Cited by 51 · see citing works
The relationship between gastric microbiota and gastric disease
Zhang, S., Shi, D., Li, M., Li, Y., Wang, X., & Li, W. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1591499 · Cited by 51 · see citing works
Influence of proton pump inhibitors on microbiota in chronic liver disease patients
Yamamoto, K., Ishigami, M., Honda, T., Takeyama, T., Ito, T., Ishizu, Y., Kuzuya, T., Hayashi, K., Goto, H., & Hirooka, Y. (2019) · Hepatology International · doi:10.1007/s12072-019-09932-9 · Cited by 50 · see citing works
Naito, Y., Takagi, T., Inoüe, R., Kashiwagi, S., Mizushima, K., Tsuchiya, S., Itoh, Y., Okuda, K., Tsujimoto, Y., Adachi, A., et al. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-26 · Cited by 49 · see citing works
Self-citationTyping of the Gut Microbiota Community in Japanese Subjects
Takagi, T., Inoüe, R., Oshima, A., Sakazume, H., Ogawa, K., Tominaga, T., Mihara, Y., Sugaya, T., Mizushima, K., Uchiyama, K., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10030664 · Cited by 49 · see citing works
Self-citationManipulation of Gut Microbiota as a Key Target for Crohn's Disease
Rashed, R. T., Valcheva, R. S., & Dieleman, L. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.887044 · Cited by 49 · see citing works
Gut microbiota profile in healthy Indonesians
Rahayu, E. S., Utami, T., Mariyatun, M., Hasan, P. N., Kamil, R. Z., Setyawan, R. H., Pamungkaningtyas, F. H., Harahap, I. A., Wiryohanjoyo, D. V., Pramesi, P. C., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i12.1478 · Cited by 42 · see citing works
Yin, Y., Sripetchwandee, J., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Anaerobe · doi:10.1016/j.anaerobe.2021.102361 · Cited by 42 · see citing works
Lee, S. M., Kim, N., Nam, R. H., Park, J. H., Choi, S. I., Park, Y., Kim, Y.-R., Seok, Y., Shin, C. M., & Lee, D. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-43112-x · Cited by 41 · see citing works
Shah, A., Talley, N. J., Koloski, N. A., Macdonald, G. A., Kendall, B. J., Shanahan, E. R., Walker, M. M., Keely, S., Jones, M. P., Morrison, M., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15786 · Cited by 41 · see citing works
Iino, C., Shimoyama, T., Chinda, D., Sakuraba, H., Fukuda, S., & Nakaji, S. (2019) · Digestion · doi:10.1159/000500634 · Cited by 40 · see citing works
Gastrointestinal Microbiome – What We Need to Know in Clinical Practice
Ortigão, R., Pimentel‐Nunes, P., Dinis-Ribeiro, M. J., & Libânio, D. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000505036 · Cited by 40 · see citing works
Proton Pump Inhibitors and Oral–Gut Microbiota: From Mechanism to Clinical Significance
Zhang, X., Li, Q., Xia, S., He, Y., Liu, Y., Yang, J., & Xiao, X. (2024) · Biomedicines · doi:10.3390/biomedicines12102271 · Cited by 37 · see citing works
Lin, C.-Y., Cheng, H., Kuo, C., Lee, Y., Sung, C., Keidan, M., Rao, K. K., Kao, J. Y., & Hsieh, S. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00486-22 · Cited by 33 · see citing works
Šegregur, D., Flanagan, T. R., Mann, J., Moir, A. J., Karlsson, Ε., Hoch, M., Carlile, D. J., Sayah‐Jeanne, S., & Dressman, J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.06.021 · Cited by 32 · see citing works
Mucosa-Associated Microbiota in the Gastrointestinal Tract of Healthy Japanese Subjects
Kashiwagi, S., Naito, Y., Inoüe, R., Takagi, T., Nakano, T., Inada, Y., Fukui, A., Katada, K., Mizushima, K., Kamada, K., et al. (2019) · Digestion · doi:10.1159/000496102 · Cited by 31 · see citing works
Self-citationProton Pump Inhibitors, H2 Blocker Use, and Risk of Inflammatory Bowel Disease in Children
Schwartz, N. R. M., Hutfless, S. M., Herrinton, L. J., Amsden, L. B., Fevrier, H. B., Giefer, M. J., Lee, D. Y., Suskind, D. L., Delaney, J. A., & Phipps, A. I. (2019) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-24.6.489 · Cited by 30 · see citing works
Kawahara, M., Kanamori, M., Meyer, G. R., Yoshinaga, T., & Itoh, N. (2018) · Fish Pathology · doi:10.3147/jsfp.53.78 · Cited by 27 · see citing works
Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients
Maeda, S., Yamaguchi, M., Maeda, K., Kobayashi, N., Izumi, N., Nagai, M., Obayashi, T., Ohashi, W., Katsuno, T., Nobata, H., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224859 · Cited by 27 · see citing works
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation
Mohamed, M. E., Saqr, A., Staley, C. M., Onyeaghala, G. C., Teigen, L. M., Dorr, C. R., Remmel, R. P., Guan, W., Oetting, W. S., Matas, A. J., et al. (2024) · Transplantation · doi:10.1097/tp.0000000000004926 · Cited by 26 · see citing works
Zhong, H., Lin, D., Lü, Z.-Y., Yang, W., & Chen, Y. (2018) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12769 · Cited by 26 · see citing works
Iron at the crossroads of host–microbiome interactions in health and disease
Choi, G., & Bessman, N. J. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02001-y · Cited by 27 · see citing works
Lassmann, Ł., Pollis, M., Żółtowska, A., & Manfredini, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071528 · Cited by 25 · see citing works
The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients
Wellhöner, F., Döscher, N., Tergast, T. L., Vital, M., Plumeier, I., Kahl, S., Potthoff, A., Manns, M. P., Maasoumy, B., Wedemeyer, H. H., et al. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1647280 · Cited by 24 · see citing works
Genetic and drug-induced hypomagnesemia: different cause, same mechanism
Bosman, W., Hoenderop, J. G. J., & de Baaij, J. H. F. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121000926 · Cited by 24 · see citing works
Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
Lin, Y.-T., Lin, T.-Y., Hung, S.-C., Liu, P.-Y., Wu, P.-H., Chuang, Y.-S., Hung, W.-C., Chiu, Y.-W., Kuo, M.-C., & Wu, C.-Y. (2021) · Microorganisms · doi:10.3390/microorganisms9020286 · Cited by 22 · see citing works
Matsuura, J., Inoüe, R., Takagi, T., Wada, S., Watanabe, A., Koizumi, T., Mukai, M., Mizuta, I., Naito, Y., & Mizuno, T. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-22 · Cited by 23 · see citing works
Self-citationMatsumoto, H., Kuroki, Y., Higashi, S., Goda, K., Fukushima, S., Katsumoto, R., Oosawa, M., Murao, T., Ishii, M., Oka, K., et al. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-3 · Cited by 22 · see citing works
Mohandas, S., Soma, V. L., Tran, T. D. B., Sodergren, E. J., Ambooken, T., Goldman, D. L., Weinstock, G. M., & Herold, B. C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.583446 · Cited by 24 · see citing works
Fong, P., Chan, S. T., Lei, P. N., Cheong, H. I., Cheong, I. M., & Hoe, W. L. (2022) · Scientific Reports · doi:10.1038/s41598-022-24244-z · Cited by 20 · see citing works
LeBaron, T. W., Sharpe, R., & Ohno, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314508 · Cited by 20 · see citing works
Enteral feeding and the microbiome in critically ill children: a narrative review
Fan, L., & Lee, J. H. (2021) · Translational Pediatrics · doi:10.21037/tp-20-349 · Cited by 19 · see citing works
Hashimoto, H., Takagi, T., Asaeda, K., Yasuda, T., Kajiwara, M., Sugaya, T., Mizushima, K., Inoue, K., Uchiyama, K., Kamada, K., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad217 · Cited by 19 · see citing works
Self-citationDurand, P., Nicco, C., Serteyn, D., Attaf, D., & Edeas, M. A. (2018) · Blood Purification · doi:10.1159/000490612 · Cited by 19 · see citing works
Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
Shi, Y., Li, J., Cai, S., Zhao, H., Zhao, H., Sun, G., & Yang, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1205348 · Cited by 18 · see citing works
Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)
Fisher, L., Fisher, A., & Smith, P. N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103253 · Cited by 18 · see citing works
Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease
Singh, N., Nugent, Z. J., Singh, H., Shaffer, S. R., & Bernstein, C. N. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad017 · Cited by 16 · see citing works
Celiac disease serology and gut microbiome following protein pump inhibitor treatment
Jang, S. S., Lebwohl, B., Abrams, J. A., Green, P. H. R., Freedberg, D. E., & Alaedini, A. (2020) · Medicine · doi:10.1097/md.0000000000021488 · Cited by 14 · see citing works
Saifon, W., Sensorn, I., Trachu, N., Oranratnachai, S., Charoenyingwattana, A., Runcharoen, C., Monnamo, N., Sukkasem, W., Inchareon, P., Suwatanapongched, T., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10050-3 · Cited by 14 · see citing works
Zhang, X., Adebayo, A. S., Wang, D., Raza, Y. N., Tomlinson, M., Dooley, H. C., Bowyer, R. C. E., Small, K. S., Steves, C. J., Spector, T. D., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4754 · Cited by 14 · see citing works
New insights into gut-liver axis in advanced liver diseases: A promising therapeutic target
Xing, Y., Ou, Y., Wang, Y., Hou, L., & Zhu, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117284 · Cited by 13 · see citing works
Fujimoto, S., Tsuruoka, N., Esaki, M., Takamori, A., Sakata, Y., Shimoda, R., Akutagawa, T., Node, K., Anzai, K., Sugisaki, N., et al. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-153 · Cited by 13 · see citing works
Esophageal Microbiome in Healthy Children and Esophageal Eosinophilia
Parashette, K. R., Sarsani, V., Toh, E. C., Janga, S. C., Nelson, D. E., & Gupta, S. K. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003413 · Cited by 13 · see citing works
Assalin, H. B., Almeida, K. C. G. D., Guadagnini, D., Santos, A., Teixeira, C. J., Bordin, S. A., Rocha, G. Z., & Saad, M. J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213766 · Cited by 15 · see citing works
Fuchs, B. B., Tharmalingam, N., & Mylonakis, E. E. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0157 · Cited by 12 · see citing works
An update on the latest chemical therapies for reflux esophagitis in children
Bardou, M., Fortinsky, K. J., Chapelle, N., Luu, M., & Barkun, A. N. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1549224 · Cited by 12 · see citing works
Hu, L., Lai, C., Li, Y. H., Sun, R., Yang, H., Liu, X., & Yu, P. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00848-x · Cited by 13 · see citing works
Chamniansawat, S., Kampuang, N., Suksridechacin, N., & Thongon, N. (2020) · Anatomical Science International · doi:10.1007/s12565-020-00572-w · Cited by 10 · see citing works
Trends in Proton Pump Inhibitor Use in Sweden by Sex and Age: A Drug Utilisation Study
Brusselaers, N., Guðnadóttir, U., Engstrand, L. G., & Lilja, H. E. (2024) · Drug Safety · doi:10.1007/s40264-024-01502-9 · Cited by 10 · see citing works
Longitudinal Microbiome Changes in Children Exposed to Proton Pump Inhibitors
Zhang, Y. J., Connearney, S., Hester, L., Du, M., Catacora, A., Akkara, A., Wen, A., Bry, L., Alm, E. J., & Rosen, R. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000703 · Cited by 9 · see citing works
Systems approaches for the clinical diagnosis of Clostridioides difficile infection
Wu, Q., & Savidge, T. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.006 · Cited by 9 · see citing works
Fossmark, R., Lirhus, S. S., & Høivik, M. L. (2023) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2255710 · Cited by 9 · see citing works
Zhang, Y., Li, J., Chen, Z., Liu, L., Zhan, X., Peng, F., Zhou, Q., Wu, X., Zeng, Y., Zhu, L., et al. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2129064 · Cited by 8 · see citing works
Hasuda, H., Ikeda, T., Makizaki, Y., Yokota, H., Tanaka, Y., Ohno, H., Shimokawa, M., Matsuoka, H., Kimura, Y., Oki, E., et al. (2022) · Surgery Today · doi:10.1007/s00595-022-02607-3 · Cited by 8 · see citing works
Skonieczna‐Żydecka, K., Stachowska, E., Maciejewska, D., Ryterská, K., Palma, J., Czerwińska-Rogowska, M., Kaczmarczyk, M., Gudan, A., Mruk, H., Świniarska, B., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102256 · Cited by 7 · see citing works
Liver cirrosis and complication risk management
Бакулин, И. Г., Oganezova, I. A., Skalinskaya, M. I., & Васильевна, С. Е. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.08.200917 · Cited by 7 · see citing works
Ichikawa, T., Hashimoto, Y., Igarashi, Y., Kawai, S., Kaji, A., Sakai, R., Osaka, T., Inoüe, R., Kashiwagi, S., Mizushima, K., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00884-y · Cited by 8 · see citing works
Self-citationGut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis
Kitae, H., Takagi, T., Naito, Y., Inoüe, R., Azuma, Y., Torii, T., Mizushima, K., Doi, T., Inoue, K., Dohi, O., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10051044 · Cited by 6 · see citing works
Self-citationOtani, K., Watanabe, T., Kosaka, S., Matsumoto, Y., Nakata, A., Nadatani, Y., Fukunaga, S., Hosomi, S., Tanaka, F., Kamata, N., et al. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-21 · Cited by 6 · see citing works
Sbeit, W., Khoury, T., Kadah, A., Asadi, W., Shahin, A., Lubany, A., Safadi, M., Haddad, H., Ahmad, R. A., Hija, S. A. E., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092966 · Cited by 6 · see citing works
Choi, H. S., Kim, M. S., Yu, M. H., You, J., Seon, D., Ko, G., Unno, T., Lee, M. Y., & Kim, Y. S. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm25024 · Cited by 5 · see citing works
Katayama, Y., Fukuda, A., Inoue, R., Kawachi, H., Sawada, R., Harada, T., Yoshimura, A., Okada, A., Shiotsu, S., Chihara, Y., et al. (2026) · ESMO Open · doi:10.1016/j.esmoop.2026.106077 · Cited by 5 · see citing works
Self-citationChanges in Gastric Microbiota during Gastric Carcinogenesis
Lee, S. (2018) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2018.18.2.95 · Cited by 5 · see citing works
A hosszú távú protonpumpagátló kezelés következményei felnőtteken
Igaz, I., Simonyi, G., Balogh, S., & Szathmári, M. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.31057 · Cited by 5 · see citing works
Evaluation of gastric acid suppression with vonoprazan using calcium carbonate breath test
Miyamoto, S., Tsuda, M., Kato, M., Mabe, K., Muto, S., Ono, S., Shimizu, Y., & Sakamoto, N. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-75 · Cited by 5 · see citing works
Condur, L., Chirila, S. I., Alexandrescu, L., Iancu, M. A., Neculau, A. E., Berariu, F. V., Toma, L., & Nicoara, A. D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155318 · Cited by 4 · see citing works
Chen, Y., Xia, S.-Y., Ru, F.-X., Feng, J.-J., Tao, J., Wei, Z.-Y., Li, X., Qian, C., Lin, Q., & Chen, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1112709 · Cited by 4 · see citing works
Iwamoto, J., Adachi, Y., Honda, A., Monma, T., & Matsuzaki, Y. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-68 · Cited by 4 · see citing works
Wen, S., Zhao, X., Lin, X., Fu, Z., Qin, S., Pan, Q., Liu, F., He, W., & Liu, T. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081059 · Cited by 3 · see citing works
Mphande, F. A., Meksang, D. S., Noranate, N., Kongpanyakul, S., Kulalert, P., Nilchan, P., & Trivijitsilp, P. (2026) · IJID Regions · doi:10.1016/j.ijregi.2026.100868 · Cited by 3 · see citing works
Dohi, O., Yasuda, T., Takagi, T., Iwai, N., Uchiyama, K., Mizushima, K., Inoüe, R., Naito, Y., & Itoh, Y. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09228-z · Cited by 4 · see citing works
Self-citationOral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice
Uchida, A., Yasuma, T., Takeshita, A., Toda, M., Okano, Y., Nishihama, K., D’Alessandro‐Gabazza, C. N., D’Alessandro, V. F., Inoue, C., Takagi, T., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s320451 · Cited by 3 · see citing works
Self-citationSbeit, W., Abukaes, H., Ahmad, H. S., Sbeit, M., Kalisky, I., Katz, L. H., Mari, A., & Khoury, T. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2106150 · Cited by 3 · see citing works
Passing the “Acid Test”: Do Proton Pump Inhibitors Affect the Composition of the Microbiome?
Dong, T. S., & Pisegna, J. R. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5273-3 · Cited by 3 · see citing works
Lepczyńska, M., Dzika, E., Chen, W., & Lu, C. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000325 · Cited by 3 · see citing works
Moaligou, C., Dion, M., Ishnaiwer, M. M., Dailly, É., Batard, É., & Javaudin, F. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad223 · Cited by 2 · see citing works
Furune, S., Suzuki, T., Honda, T., Yamamoto, K., Furukawa, K., Nakamura, M., Ishigami, M., Kinoshita, F., Kadota, Y., Tochio, T., et al. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16445 · Cited by 2 · see citing works
- Authors
- Takagi, T., Naito, Y., Inoue, R., Kashiwagi, S., Uchiyama, K., Mizushima, K., Tsuchiya, S., Okayama, T., Dohi, O., Yoshida, N., Kamada, K., Ishikawa, T., Handa, O., Konishi, H., Okuda, K., Tsujimoto, Y., Ohnogi, H., & Itoh, Y.
- Affiliations
- Kyoto Prefectural University of Medicine (JP)
- Laboratory of Animal Science, Kyoto Prefectural University
- Takara BIO Inc. (Japan) (JP)
- Corresponding author
- Takagi, Tomohisa
- ORCID
- Venue
- Journal of Clinical Biochemistry and Nutrition
- Published
- 2018
- Volume
- 62
- Issue
- 1
- Pages
- 100-105
- ISSN
- 0912-0009 (ISSN-L)
- 1880-5086
- PMC
- PMC5773837
- OpenAlex
- W2771725285
- Cited by
- 121
- References
- 23
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 9 · 2023: 11 · 2022: 20 · 2021: 9 · 2020: 20 · 2019: 22 · 2018: 15
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Journal of Clinical Biochemistry and Nutrition (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Agriculture and Food Research Organization
- Japan Society for the Promotion of Science (16K09322, 16H05289)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Keywords
- proton pump inhibitors, gut microbiota, Clostridium difficile infection, gastrointestinal infections, Faecalibacterium, Streptococcus, microbial diversity, fecal microbiota, long-term drug use, Japanese adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
